Published on 27 Mar 2024 on GuruFocus.com via Yahoo Finance
AbbVie: An Undervalued Giant
AbbVie Inc. (NYSE:ABBV) has made a decent recovery this year, jumping 11%.
However, no good deed goes unpunished on Wall Street, so it still represents an underdog of the market as, even now, it trades at a valuation even lower than the average price-earnings ratio of the industry.
An undervalued giant of this kind could be a solid investment play as it grows its revenue base.